Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-008870
Filing Date
2021-04-15
Accepted
2021-04-15 16:15:47
Documents
54
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 393628
2 ex31-1.htm EX-31.1 12792
3 ex31-2.htm EX-31.2 12800
4 ex32-1.htm EX-32.1 7054
5 ex32-2.htm EX-32.2 6906
  Complete submission text file 0001493152-21-008870.txt   2789550

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bblg-20200331.xml EX-101.INS 459435
7 XBRL SCHEMA FILE bblg-20200331.xsd EX-101.SCH 39948
8 XBRL CALCULATION FILE bblg-20200331_cal.xml EX-101.CAL 35736
9 XBRL DEFINITION FILE bblg-20200331_def.xml EX-101.DEF 124461
10 XBRL LABEL FILE bblg-20200331_lab.xml EX-101.LAB 281546
11 XBRL PRESENTATION FILE bblg-20200331_pre.xml EX-101.PRE 207988
Mailing Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803
Business Address 2 BURLINGTON WOODS DRIVE, SUITE 100, BURLINGTON MA 01803 (781) 552-4452
Bone Biologics Corp (Filer) CIK: 0001419554 (see all company filings)

EIN.: 421743430 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53078 | Film No.: 21828649
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies